Neosar

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

43 API Suppliers, 21 USDMF, 6 CEP/COS, 7 EU WC, 18 NDC API, 19 Listed Suppliers

DEVELOPMENTS

494 Drugs in Development

494 Drugs in Development

INTERMEDIATES

4 Intermediate Suppliers

4 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

195 FDF Dossiers, 87 FDA Orange Book, 60 Europe, 10 Canada, 9 Australia, 6 South Africa, 23 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - 100MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - 1GM/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - 200MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - 2GM/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - 500MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE;ORAL - 25MG, CAPSULE;ORAL - 50MG, SOLUTION;INTRAVENOUS - 1GM/5ML (200MG/ML), SOLUTION;INTRAVENOUS - 2GM/10ML (200MG/ML), SOLUTION;INTRAVENOUS - 500MG/2.5ML (200MG/ML)

RELATED EXCIPIENT COMPANIES

1 Minakem, 2 Rochem International Inc, 18 SPI Pharma, 6 Gangwal Healthcare, 2 Nanjing Well Pharmaceutical, 1 Shanghai Minbiotech, 1 Pfanstiehl, 1 Panvo Organics, 1 Dr. Paul Lohmann GmbH & Co. KGaA, 4 ACG Worldwide, 3 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 2 BASF, 4 DFE Pharma, 1 Finar, 4 Gangwal Chemicals, 1 Gloria Interchem, 1 Ideal Cures, 3 Ingredion Pharma Solutions, 11 Kerry, 1 Keval Exports, 3 Lonza Capsugel, 11 Microlex e.U, 1 Neelkanth MineChem, 3 Nitika Pharmaceutical Specialities, 2 Pharmatrans-Sanaq, 4 Pluviaendo, 2 Prachin Pharmachem, 1 Qualicaps, 17 Roquette, 2 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 8 Sigachi Industries, 2 Silverline Chemicals, 1 Valens Pharmachem, 2 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

54 Fillers, Diluents & Binders, 25 Direct Compression, 18 Chewable & Orodispersible Aids, 15 Lubricants & Glidants, 15 Granulation, 15 Taste Masking, 13 Co-Processed Excipients, 12 Thickeners and Stabilizers, 12 Disintegrants & Superdisintegrants, 8 Empty Capsules, 6 Coating Systems & Additives, 6 Parenteral, 5 Film Formers & Plasticizers, 4 Emulsifying Agents, 3 Solubilizers, 3 Topical, 3 Controlled & Modified Release, 1 Rheology Modifiers, 1 API Stability Enhancers

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 77 News #PharmaBuzz

GLOBAL SALES INFORMATION

12 US Medicaid Prescriptions, 3 Regulatory FDF Prices

MARKET PLACE

14 APIs, 18 FDF Dossiers

PATENTS & EXCLUSIVITIES

15 US Patents

15 US Patents

REF. STANDARDS & IMPURITIES

1 EDQM, 8 Others

Xls

Filters

Neosar

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

Looking for Neosar? Find Coloring Agents used in Neosar to address drug delivery challenges on PharmaCompass.

Neosar

ACCESS ALL DATA

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

43 API Suppliers

21 USDMF

6 CEP/COS

7 EU WC

18 NDC API

19 Listed Suppliers

DEVELOPMENTS

494 Drugs in Development

INTERMEDIATES

4 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

195 FDF Dossiers

87 FDA Orange Book

60 Europe

10 Canada

9 Australia

6 South Africa

23 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - 100MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - 1GM/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - 200MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - 2GM/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - 500MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE;ORAL - 25MG

CAPSULE;ORAL - 50MG

SOLUTION;INTRAVENOUS - 1GM/5ML (200MG/ML)

SOLUTION;INTRAVENOUS - 2GM/10ML (200MG/ML)

SOLUTION;INTRAVENOUS - 500MG/2.5ML (200MG/ML)

RELATED EXCIPIENT COMPANIES

1 Minakem

2 Rochem International Inc

18 SPI Pharma

6 Gangwal Healthcare

2 Nanjing Well Pharmaceutical

1 Shanghai Minbiotech

1 Pfanstiehl

1 Panvo Organics

1 Dr. Paul Lohmann GmbH & Co. KGaA

4 ACG Worldwide

3 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

2 BASF

4 DFE Pharma

1 Finar

4 Gangwal Chemicals

1 Gloria Interchem

1 Ideal Cures

3 Ingredion Pharma Solutions

11 Kerry

1 Keval Exports

3 Lonza Capsugel

11 Microlex e.U

1 Neelkanth MineChem

3 Nitika Pharmaceutical Specialities

2 Pharmatrans-Sanaq

4 Pluviaendo

2 Prachin Pharmachem

1 Qualicaps

17 Roquette

2 Seppic

4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Shijiazhuang Huaxu Pharmaceutical

8 Sigachi Industries

2 Silverline Chemicals

1 Valens Pharmachem

2 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

54 Fillers, Diluents & Binders

25 Direct Compression

18 Chewable & Orodispersible Aids

15 Lubricants & Glidants

15 Granulation

15 Taste Masking

13 Co-Processed Excipients

INJECTABLE;INJECTION - 100MG/VIAL Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

INJECTABLE;INJECTION - 1GM/VIAL Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

INJECTABLE;INJECTION - 200MG/VIAL Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

INJECTABLE;INJECTION - 2GM/VIAL Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

INJECTABLE;INJECTION - 500MG/VIAL Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons